Sex-based differences in outcomes after percutaneous coronary intervention for acute myocardial infarction: a report from TRANSLATE-ACS.
Abstract
BACKGROUND: Data regarding sex-based outcomes after percutaneous coronary intervention
(PCI) for myocardial infarction are mixed. We sought to examine whether sex differences
in outcomes exist in contemporary practice. METHODS AND RESULTS: We examined acute
myocardial infarction patients undergoing PCI between April 2010 and October 2012
at 210 US hospitals participating in the Treatment with Adenosine Diphosphate Receptor
Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary
Syndrome (TRANSLATE-ACS) observational study. Outcomes included 1-year risk of major
adverse cardiac events and bleeding according to Global Utilization of Strategies
To Open Occluded Arteries (GUSTO) and Bleeding Academic Research Consortium (BARC)
definitions. Among 6218 patients, 27.5% (n=1712) were female. Compared with men, women
were older, had more comorbidities, and had lower functional status. Use of multivessel
PCI and drug-eluting stents was similar between sexes, while women received less prasugrel.
Unadjusted cumulative incidence of 1-year major adverse cardiac events was higher
for women than for men (15.7% versus 13.6%, P=0.02), but female sex was no longer
associated with higher incidence of major adverse cardiac events after multivariable
adjustment (hazard ratio 0.98, 95% CI 0.83 to 1.15). Female sex was associated with
higher risks of post-PCI GUSTO bleeding (9.1% versus 5.7%, P<0.0001) and postdischarge
BARC bleeding (39.6% versus 27.9%, P<0.0001). Differences persisted after adjustment
(GUSTO: hazard ratio 1.32, 95% CI 1.06 to 1.64; BARC: incidence rate ratio 1.42, 95%
CI 1.27 to 1.56). CONCLUSIONS: Female and male myocardial infarction patients undergoing
PCI differ regarding demographic, clinical, and treatment profiles. These differences
appear to explain the higher observed major adverse cardiac event rate but not higher
adjusted bleeding risk for women versus men.
Type
Journal articleSubject
acute myocardial infarctionmajor adverse cardiac events
percutaneous coronary intervention
sex‐based outcomes
Age Factors
Aged
Comorbidity
Drug-Eluting Stents
Female
Health Status Disparities
Healthcare Disparities
Hemorrhage
Humans
Longitudinal Studies
Male
Middle Aged
Myocardial Infarction
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Prospective Studies
Purinergic P2Y Receptor Antagonists
Risk Factors
Sex Factors
Time Factors
Treatment Outcome
United States
Permalink
https://hdl.handle.net/10161/15014Published Version (Please cite this version)
10.1161/JAHA.113.000523Publication Info
Hess, Connie N; McCoy, Lisa A; Duggirala, Hesha J; Tavris, Dale R; O'Callaghan, Kathryn;
Douglas, Pamela S; ... Wang, Tracy Y (2014). Sex-based differences in outcomes after percutaneous coronary intervention for acute
myocardial infarction: a report from TRANSLATE-ACS. J Am Heart Assoc, 3(1). pp. e000523. 10.1161/JAHA.113.000523. Retrieved from https://hdl.handle.net/10161/15014.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Pamela Susan Douglas
Ursula Geller Distinguished Professor of Research in Cardiovascular Diseases
Pamela S Douglas MD is the Ursula Geller Professor of Research in Cardiovascular Diseases
in the Department of Medicine at Duke University and Director of the Multimodality
Imaging Program at Duke Clinical Research Institute. During her 30+ years of experience
she has led several landmark multicenter government studies and pivotal industry clinical
trials along with outcomes research studies. She is renowned for her scientific and
policy work in improving the quality and appropriateness
Eric David Peterson
Fred Cobb, M.D. Distinguished Professor of Medicine
Dr Peterson is the Fred Cobb Distinguished Professor of Medicine in the Division of
Cardiology, a DukeMed Scholar, and the Past Executive Director of the Duke Clinical
Research Institute (DCRI), Durham, NC, USA.
Dr Peterson is the Principal Investigator of the National Institute of Health, Lung
and Blood Institute (NHLBI) Spironolactone Initiation Registry Randomized Interventional
Trial in Heart Failure With Preserved Ejection Fraction (SPIRRIT) Trial He is also
the Principal I
This author no longer has a Scholars@Duke profile, so the information shown here reflects
their Duke status at the time this item was deposited.
Tracy Yu-Ping Wang
Professor of Medicine
This author no longer has a Scholars@Duke profile, so the information shown here reflects
their Duke status at the time this item was deposited.
Alphabetical list of authors with Scholars@Duke profiles.

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info